Bemarituzumab
Bemarituzumab Uses, Dosage, Side Effects, Food Interaction and all others data.
Bemarituzumab is under investigation in clinical trial NCT03694522 (A Study of Bemarituzumab (FPA144) Combined With Modified FOLFOX6 (Mfolfox6) in Gastric/gastroesophageal Junction Cancer (FIGHT)).
| Trade Name | Bemarituzumab |
| Generic | Bemarituzumab |
| Bemarituzumab Other Names | Anti-fgfr2 monoclonal antibody fpa144, Bemarituzumab |
| Type | |
| Groups | Investigational |
| Therapeutic Class | |
| Manufacturer | |
| Available Country | |
| Last Updated: | September 19, 2023 at 7:00 am |
Innovators Monograph
You find simplified version here Bemarituzumab
